Related Experiment Video
Updated: May 19, 2026

Cellular Encapsulation in 3D Hydrogels for Tissue Engineering
Published on: October 26, 2009
Covalent cross-linking approaches for all-trans retinoic acid-loaded thermo-responsive hydrogels
Xueli Mei1, Robert C Stewart2, Xiao Zhen Zhou2,3,4
1Department of Chemistry, The University of Western Ontario, 1151 Richmond St., London, Ontario N6A 5B7, Canada. egillie@uwo.ca.
Abstract:
All-trans retinoic acid (ATRA) is a promising therapeutic for the treatment of a wide range of cancers. However, its short half-life, poor water-solubility, and low stability in vivo hinder its use. The development of injectable controlled release systems for ATRA delivery can potentially address these challenges. Building on a poly(caprolactone-co-lactide)-poly(ethylene glycol)-poly(caprolactone-co-lactide) (PCLA-PEG-PCLA) triblock copolymer system that undergoes thermo-responsive gelation at 37 °C, we explore and compare different approaches to stabilize the gels through covalent bonding. The attempted cross-linking of methacrylate end-capped PCLA-PEG-PCLA through thiol-Michael addition reactions using small molecule and 4-arm-PEG thiols led to precipitation rather than gelation. However, azide end-capped PCLA-PEG-PCLA was gelled using 5 kg mol-1 4-arm-PEG with terminal dibenzocyclooctyne (DIBAC) groups by strain-promoted azide-alkyne cycloaddition. This hydrogel was then compared with previously reported methacrylate end-capped PCLA-PEG-PCLA hydrogels cross-linked by free radical chemistry, as well as non-covalently cross-linked hydrogels. The azide-alkyne hydrogels exhibited properties intermediate between the free radical and non-covalently cross-linked gels. Incorporation of ATRA substantially disrupted the free radical cross-linking, but imparted only modest changes in the azide-alkyne gels. ATRA was released over about two weeks. The proliferation of MDA-MB-468 cells in the presence of ATRA-loaded and control azide-alkyne gels was investigated. The ATRA-loaded gel released active drug, while the unloaded gel did not affect proliferation.
Insights
Researchers developed a new injectable hydrogel for controlled release of all-trans retinoic acid (ATRA), a cancer therapy. The azide-alkyne cross-linked hydrogel showed promising drug release and stability for cancer treatment applications.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery Systems
Background:
- All-trans retinoic acid (ATRA) shows therapeutic potential for various cancers but faces limitations like poor solubility and short in vivo half-life.
- Injectable controlled-release systems are crucial for overcoming ATRA's delivery challenges.
- Thermo-responsive poly(caprolactone-co-lactide)-poly(ethylene glycol)-poly(caprolactone-co-lactide) (PCLA-PEG-PCLA) triblock copolymers offer a basis for such systems.
Purpose of the Study:
- To investigate and compare covalent cross-linking strategies for stabilizing thermo-responsive PCLA-PEG-PCLA hydrogels for ATRA delivery.
- To evaluate the impact of different cross-linking methods on hydrogel properties and ATRA encapsulation/release.
- To assess the in vitro efficacy of ATRA-loaded hydrogels in a cancer cell model.
Main Methods:
- Synthesis of azide end-capped PCLA-PEG-PCLA and cross-linking via strain-promoted azide-alkyne cycloaddition with 4-arm-PEG-DIBAC.
- Comparison of azide-alkyne hydrogels with methacrylate-based hydrogels (free radical and thiol-Michael addition) and non-covalently cross-linked systems.
- Encapsulation of all-trans retinoic acid (ATRA) and evaluation of its release kinetics over two weeks.
- Assessment of ATRA-loaded hydrogel's effect on MDA-MB-468 cell proliferation.
Main Results:
- Thiol-Michael addition failed to form gels; azide-alkyne cycloaddition successfully formed stable hydrogels.
- Azide-alkyne hydrogels demonstrated properties intermediate between free radical and non-covalently cross-linked gels.
- ATRA incorporation moderately affected azide-alkyne hydrogel properties but significantly disrupted free radical cross-linking.
- ATRA was released over approximately two weeks, and ATRA-loaded gels inhibited cancer cell proliferation.
Conclusions:
- Strain-promoted azide-alkyne cycloaddition provides a viable method for creating stable, injectable ATRA-releasing hydrogels from PCLA-PEG-PCLA copolymers.
- The developed hydrogel system offers controlled release of ATRA, maintaining its therapeutic activity.
- This approach holds promise for improving cancer therapy through enhanced drug delivery.
More Related Videos
09:30The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
Published on: October 7, 2016
12:07Fabricating Degradable Thermoresponsive Hydrogels on Multiple Length Scales via Reactive Extrusion, Microfluidics, Self-assembly, and Electrospinning
Published on: April 16, 2018
Related Concept Videos
Balancing Redox Equations
Reduction of Alkynes to trans-Alkenes: Sodium in Liquid Ammonia
When dissolved in liquid ammonia, an alkali metal, such as sodium, dissociates into a...
Redox Equilibria: Overview
Ion Exchange
Equivalent Resistance
Transport Number